EnteroMedics recruits new patients with media effort
EnteroMedics, a device company founded in 2002, plans to present clinical trial data to the FDA next year as part of its pre-market approval bid for VBLOC Therapy, a noninvasive device that targets the vagal nerve and can help obese patients to lose weight.

Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>